// App-Quantinova.ai

2445 : Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT

Researchers

Presenter

  • Josu de la Fuente

Principal Investigators

  • Paul Bosman

  • Robert F Wynn

  • Miguel Daz

  • Peter J Shaw

  • Amal Al-Seraihy

  • Muhlis Cem Ar

  • Mohamed Salaheldin Mohamed

  • Dominique Bron

  • Cristina Daz de Heredia

  • Tobias Gedde-Dahl

  • Brenda Gibson

  • Rupert Handgretinger

  • John G. Gribben

  • Tessa Kerre

  • Vassiliki Kitra-Roussou

  • Stig Lenhoff

  • Jose Maria Moraleda

  • Antonio Perez Martinez

  • John Moppett

  • Henrik Sengeloev

  • Abdelghani Tbakhi

  • Hendrik Veelken

  • Estelle Verburgh

  • Giuseppe Visani

  • Antonio Risitano

  • Carlo Dufour

  • Selim Corbacioglu

  • Regis Peffault De Latour

Medical Centers

  • Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

  • LUMC, Dept. Medical Statistics & Bioinformatics, Leiden, Netherlands

  • EBMT Leyden Office, Leyden, The Netherlands,

  • Royal Manchester Children's Hospital, Manchester, United Kingdom

  • HOSPITAL NiÑO JESUS, MADRID, ESP

  • The Children's Hospital at Westmead, Sydney, AUS

  • King Faisal Hospital and Research Centre Riyadh, Riyadh, Saudi Arabia

  • Department of Internal Medicine, Division of Hematology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

  • Dpt of Hematology, Institut Jules Bordet, ULB, 1 Rue Heger Bordet, Belgium

  • Hospital Universitario del Mar, Barcelona, Spain

  • Department ofHaematology, Oslo University Hospital and Instituteof Clinical Medicine University of Oslo, Oslo,Norway

  • Department of Hematology, Royal Hospital for Children, Glasgow, GBR

  • Hematology and Oncology, Children`s University Hospital Tubingen, Tubingen, Germany

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Department of Radiation Oncology, Ghent University Hospital, Gent, Belgium

  • St. Sophia Childrens Hospital, Athens, Greece

  • Lund University Hospital, Lund, Sweden

  • Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain., Murcia, Spain

  • Hospital Infantil Universitario Nino Jesus, Madrid, Spain

  • Bristol Royal Hospital for Children, Bristol, United Kingdom

  • Rigshospitalet, Copenhagen, Denmark

  • Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Aurora, Canada

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Groote Schuur Hospital, Cape Town, South Africa

  • Hematology & Transplant Centre, AORMN Hospital, Pesaro, Italy

  • Department of clinical medicine and surgery, University of Naples Federico II, Naples, Italy

  • Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy

  • Internal Medicine III, Department of Hematology, Oncology and Stem Cell Transplantation, University Hospital Regensburg, Regensburg, Germany

  • French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique – Hôpitaux de Paris, Université de Paris, Paris, France

Locations

  • United Kingdom

  • Netherlands

  • Saudi Arabia

  • Turkey

  • Belgium

  • Spain

  • Norway

  • Germany

  • Greece

  • Sweden

  • Denmark

  • Jordan

  • South Africa

  • Italy

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Hemochromatosis

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Alemtuzumab

  • fludarabine tablet

  • Ovastat

  • sulfur topical

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved